Central Corneal Thickness Correction for Goldmann IOP
Goldmann tonometry assumes CCT of 520–545 µm. Thin corneas under-read, thick corneas over-read true IOP. Approximate corrections: Ehlers (~5 mmHg per 70 µm), Dresdner (~1 mmHg per 25 µm), Doughty meta-analysis (~2.5 mmHg per 50 µm). Pick the CCT band to apply the typical adjustment.
Score interpretation
→ Treat as higher-than-measured IOP. OHTS demonstrated CCT <555 µm is an independent risk factor (3× hazard) for glaucoma conversion. Lower IOP target; expedite SLT or PGA. Important after refractive surgery (LASIK/PRK).
→ Increase risk weight in glaucoma decision. Consider lower target IOP and tighter monitoring. Per NICE NG81, factor CCT into treatment threshold for OHT.
→ Goldmann readings are a reliable estimate of true IOP. Standard glaucoma management.
→ True IOP slightly lower than measured. Avoid over-treatment of pseudo-OHT; correlate with optic disc and field findings before initiating drops.
→ Likely pseudo-OHT. Reassess true IOP with pneumotonometry / dynamic contour tonometry; defer treatment if disc and fields normal. Ehlers correction may overestimate — interpret cautiously.
Interpretation bands for the CCT Correction. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Netarsudil 0.02% Eye Drops · Rho-kinase (ROCK) Inhibitor — Glaucoma
- Tafluprost 0.0015% Eye Drops · Prostaglandin Analogue — Glaucoma (Preservative-Free)
- Dorzolamide / Timolol Fixed Combination (Cosopt) · Fixed Combination Glaucoma Treatment — CAI + Beta-blocker
- Latanoprostene Bunod 0.024% Eye Drops · Nitric Oxide-donating Prostaglandin Analogue — Glaucoma
- Brimonidine / Timolol Fixed Combination · Fixed Combination Glaucoma Treatment — Alpha-2 Agonist + Beta-blocker
- Betaxolol 0.5% Eye Drops · Cardioselective Beta-1 Blocker — Glaucoma
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.